Rockland Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Buy
177,097
+163
+0.1% +$14.3K 0.64% 46
2026
Q1
$15.1M Sell
176,934
-2,854
-2% -$254K 0.6% 51
2025
Q4
$14.2M Buy
179,788
+9,833
+6% +$771K 0.56% 53
2025
Q3
$13.6M Buy
169,955
+3,348
+2% +$286K 0.56% 56
2025
Q2
$15.1M Sell
166,607
-104
-0.1% -$9.49K 0.74% 44
2025
Q1
$15.6M Sell
166,711
-1,090
-0.6% -$97.6K 0.79% 41
2024
Q4
$15.3M Sell
167,801
-10,348
-6% -$987K 0.78% 40
2024
Q3
$18.5M Sell
178,149
-64,449
-27% -$6.57M 0.91% 38
2024
Q2
$23.5M Sell
242,598
-5,056
-2% -$466K 1.24% 25
2024
Q1
$22.3M Sell
247,654
-82,938
-25% -$7.03M 1.18% 27
2023
Q4
$26.4M Buy
330,592
+11,006
+3% +$828K 1.44% 22
2023
Q3
$22.7M Buy
319,586
+47,906
+18% +$3.58M 1.37% 25
2023
Q2
$20.9M Buy
271,680
+5,480
+2% +$424K 1.25% 23
2023
Q1
$20M Buy
266,200
+14,193
+6% +$1.06M 1.26% 22
2022
Q4
$19.9M Buy
252,007
+6,508
+3% +$488K 1.26% 21
2022
Q3
$17.2M Buy
245,499
+9,066
+4% +$711K 1.23% 25
2022
Q2
$18.9M Buy
236,433
+19,428
+9% +$1.52M 1.31% 20
2022
Q1
$16.5M Buy
217,005
+33,409
+18% +$2.65M 1.05% 32
2021
Q4
$15.7M Buy
183,596
+13,840
+8% +$1.08M 1% 32
2021
Q3
$12.8M Buy
169,756
+2,130
+1% +$169K 0.89% 38
2021
Q2
$13.6M Buy
167,626
+2,059
+1% +$168K 0.94% 40
2021
Q1
$13.1M Buy
165,567
+1,505
+0.9% +$118K 0.94% 35
2020
Q4
$14M Sell
164,062
-1,437
-0.9% -$119K 1.09% 34
2020
Q3
$12.8M Sell
165,499
-2,243
-1% -$171K 1.1% 34
2020
Q2
$12.3M Buy
167,742
+498
+0.3% +$35.4K 1.1% 29
2020
Q1
$11.1M Buy
167,244
+4,846
+3% +$342K 1.13% 31
2019
Q4
$11.2M Buy
162,398
+8,281
+5% +$565K 0.92% 44
2019
Q3
$10.9M Buy
154,117
+3,443
+2% +$250K 0.99% 41
2019
Q2
$10.8M Buy
150,674
+3,764
+3% +$267K 1.07% 39
2019
Q1
$10.1M Buy
146,910
+2,817
+2% +$182K 1.07% 36
2018
Q4
$8.58M Buy
144,093
+140,638
+4,071% +$8.8M 1.05% 38
2018
Q3
$231K Buy
+3,455
New +$230K 0.03% 203
2018
Q2
Sell
-3,270
Closed -$234K 203
2018
Q1
$234K Sell
3,270
-290
-8% -$20.9K 0.03% 187
2017
Q4
$269K Buy
+3,560
New +$260K 0.03% 176
2016
Q4
Sell
-3,830
Closed -$284K 164
2016
Q3
$284K Sell
3,830
-102
-3% -$7.54K 0.05% 132
2016
Q2
$288K Sell
3,932
-790
-17% -$56.3K 0.05% 130
2016
Q1
$334K Sell
4,722
-550
-10% -$36.6K 0.06% 122
2015
Q4
$351K Buy
5,272
+494
+10% +$32.9K 0.06% 127
2015
Q3
$303K Sell
4,778
-40
-0.8% -$2.61K 0.06% 123
2015
Q2
$315K Sell
4,818
-794
-14% -$53.9K 0.06% 114
2015
Q1
$389K Sell
5,612
-100
-2% -$6.91K 0.08% 102
2014
Q4
$395K Buy
5,712
+66
+1% +$4.46K 0.08% 103
2014
Q3
$368K Hold
5,646
0.08% 99
2014
Q2
$385K Buy
5,646
+560
+11% +$37.5K 0.09% 93
2014
Q1
$330K Buy
5,086
+898
+21% +$56.6K 0.08% 95
2013
Q4
$273K Hold
4,188
0.07% 100
2013
Q3
$248K Hold
4,188
0.07% 99
2013
Q2
$240K Buy
+4,188
New +$249K 0.07% 104

Other funds holding CL

Rockland Trust's CL Position: Q2 2026 in Review

Rockland Trust increased its Colgate-Palmolive (CL) stake by 0.09% in Q2 2026, buying an estimated $14.3K and bringing the position to 177,097 shares worth $16.2M. The position accounts for 0.64% of the portfolio, ranked #46.

Rockland Trust first reported a position in CL in Q2 2013 and has held it in 48 quarters since. The position peaked at $26.4M in Q4 2023. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Rockland Trust held 177,097 shares of Colgate-Palmolive worth $16.2M as of Q2 2026.
  • Rockland Trust bought 163 Colgate-Palmolive shares in Q2 2026, an estimated $14.3K.
  • Colgate-Palmolive made up 0.64% of Rockland Trust's portfolio in Q2 2026, its #46 holding.
  • Rockland Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 48 quarters since.
  • Rockland Trust's Colgate-Palmolive position peaked at $26.4M in Q4 2023.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.